Anti-Human IL23 Therapeutic Antibody (Tildrakizumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human IL23. Tildrakizumab is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-875 |
Pricing | Inquiry |
Host | Mouse |
Target | IL23 |
Species Reactivity | Human |
Type | IgG1 - kappa |
Applications | Neut, ELISA, IF, IP, FuncS, FC, ICC |
Storage | At -20°C for one year. |